Results 11 to 20 of about 4,239,494 (310)

Evaluation of Clinical and Immunological Markers for predicting Virological Failure in a HIV/AIDS treatment cohort in Busia, Kenya [PDF]

, 2012
In resource-limited settings where viral load (VL) monitoring is scarce or unavailable, clinicians must use immunological and clinical criteria to define HIV virological treatment failure. This study examined the performance of World Health Organization (
A Calmy, Ana Alvarez, Andrea Bernasconi, Ashimosi S. Khamadi, Cecilia Ferreyra, David Dalmau, DM Moore, Elena Alonso, Elena Velilla, J Mermin, JH Elliott, JM Tassie, Laurence Flevaud, Martha Kihara Mugendi, Matilu Mwau, Mireia Arnedo, Nell Eisenberg, O Keiser, O Keiser, Oliver Yun, P Braitstein, P Braitstein, P Mee, Paul Roddy, Pedro Pablo Palma, R Barth, R Colebunders, S Bagchi, S Reynolds, S Rosen, Stefan Pöhlmann   +30 more
core   +20 more sources

Cellulitis: Treatment failure or failure to define treatment failure? [PDF]

Emergency Medicine Australasia, 2020
Dear Editor, Cellulitis is a common ED diagnosis and antibiotics are part of routine management. Each year, almost 60 000 people are hospitalised for treatment of cellulitis in Australia, of which an estimated 11% were deemed preventable.1 Appropriate antibiotic selection involves the right antibiotic type, dosage and route of administration.
Nimai Etheridge, Gerben Keijzers
openaire   +3 more sources

Treatment failure in osteoporosis [PDF]

Osteoporosis International, 2012
Guidelines concerning the definition of failure of therapies used to reduce the risk of fracture are provided.This study aims to provide guidelines concerning the definition of failure of therapies used to reduce the risk of fracture.A working group of the Committee of Scientific Advisors of the International Osteoporosis Foundation was convened to ...
Diez-Perez, A, Adachi, JD, Agnusdei, D, Bilezikian, JP, Compston, JE, Cummings, SR, Eastell, R, Eriksen, EF, Gonzalez-Macias, J, Liberman, UA, Wahl, DA, Seeman, E, Kanis, JA, Cooper, C   +13 more
openaire   +4 more sources

Heart failure drug treatment [PDF]

The Lancet, 2019
Heart failure is the most common cardiovascular reason for hospital admission for people older than 60 years of age. Few areas in medicine have progressed as remarkably as heart failure treatment over the past three decades. However, progress has been consistent only for chronic heart failure with reduced ejection fraction.
Patrick, Rossignol, Adrian F, Hernandez, Scott D, Solomon, Faiez, Zannad   +3 more
openaire   +2 more sources

Treatment failure in tuberculosis [PDF]

European Respiratory Journal, 2006
Treatment of latent tuberculosis (TB) infection with 3 months of rifampicin/isoniazid is a major part of preventive TB programmes. The effectiveness of treatment of latent TB infection can only be assessed by rates of subsequent breakdown and there are few outcome data for this combination of rifampicin/isoniazid.
J R, Panickar, W, Hoskyns
openaire   +2 more sources

Local treatment failure after globe-conserving therapy for choroidal melanoma. [PDF]

, 2013
Local treatment failure after globe-conserving therapy for choroidal melanoma is a surgical complication with significant morbidity to the vision and eye. Few reports in the literature have addressed this complication exclusively.
Chang, Melinda Y, McCannel, Tara A
core   +1 more source

B-type natriuretic peptide-guided treatment for heart failure [PDF]

, 2016
Background Heart failure is a condition in which the heart does not pump enough blood to meet all the needs of the body. Symptoms of heart failure include breathlessness, fatigue and fluid retention.
Bankhead, Clare, Clements, Alison M, Glasziou, Paul P, Heneghan, Carl J., Kearley, Karen E, McLellan, Julie, Perera, Rafael, Pidduck, Nicola, Roberts, Nia W, Tyndel, Sally, Wright, F Lucy   +10 more
core   +1 more source

Usefulness of serum thyroid-stimulation hormone (TSH) as a prognostic indicator for acute-on-chronic liver failure

Annals of Hepatology, 2015
Background and rationale for the study. To investigate thyroid function in patients with acute-on-chronic liver failure (ACLF) caused by hepatitis B virus infection and to determine whether thyroid hormone levels can be used as prognostic markers for ...
Yichen Wu, Shaoli You, Hong Zang, Hongling Liu, Yuanli Mao, Panyong Mao, Bing Zhu, Jun Xu, Guoming Xie, Jingxia Guo, Dongze Li, Shaojie Xin, Zhihong Wan   +12 more
doaj   +1 more source

Non-adherence to ivabradine and placebo and outcomes in chronic heart failure: an analysis from SHIFT [PDF]

, 2016
Aims In heart failure, non-adherence increases events; in turn, the effect of hospitalization on adherence is incompletely understood. We explored the relationship of non-adherence to outcomes, hospitalizations with non-adherence, and the influence of
Alosco, Ambardekar, Ammassari, Balkrishnan, Böhm, Böhm, Böhm, Chobanian, Claxton, Coronary Drug Project Research Group, De Geest, Ewen, Fang, Fitzgerald, Ford, Gislason, Goldberg, Granger, Havranek, Ho, Horwitz, Jong, Laufs, Masoudi, Mazzaglia, McMurray, Mosterd, Osterberg, Rasmussen, Roger, Simpson, Swedberg, Swedberg, Vrijens, Wu, Yue   +35 more
core   +1 more source

Virologic failure and second-line antiretroviral therapy in children in South Africa--the IeDEA Southern Africa collaboration [PDF]

, 2011
Article approval pendingWith expanding pediatric antiretroviral therapy (ART) access, children will begin to experience treatment failure and require second-line therapy. We evaluated the probability and determinants of virologic failure and switching in
Boulle, Andrew, Davies, Mary-Ann, Egger, Matthias, Eley, Brian, Giddy, Janet, Keiser, Olivia, Moultrie, Harry, Rabie, Helena, Technau, Karl, Van Cutsem, Gilles, Wood, Robin   +10 more
core   +2 more sources